In a rare meeting, the Trump administration invited all 100 U.S. senators for a White House closed-door briefing on North Korea, as Pyongyang parades its nuclear might and the U.S. considers action.
Despite the number of potential risks associated with the developing economies, emerging markets and related exchange traded funds have been able to maintain their momentum and may still have legs to run. Year-to-date, the Vanguard FTSE Emerging Markets ETF (NYSEArca: VWO) and the iShares MSCI Emerging Markets ETF (NYSEArca: EEM), the two largest emerging markets…
A strong earnings report showed investors that FCA's profit-boosting plan is working.
An executive order that President Trump signed Wednesday requires the Interior Department to review the hundreds of millions of acres that former presidents have since 1993 designated as national monuments.
Wall Street cheers as the Texas-based bank reported double-digit growth in profits.
Facebook (NASDAQ:FB) is touting its booming Instagram unit – which just hit 700 million monthly active users – as it continues to face backlash for graphic videos being posted via its “Live” feature.
Looking for stocks with an unbeatable track record? Here are three that have crushed the market over the last five years.
In an effort to clamp down on a disturbing trend targeting cancer patients, the Food and Drug Administration (FDA) recently sent warning letters to 14 companies ordering them to stop peddling fraudulent cure-all remedies — or else face possible criminal prosecution.
An impressive 190 of the companies in the S&P 500 are reporting earnings this week, but the Market Foolery team has more to talk about than just quarterly profits.
Researchers have taken an important step toward better lung cancer treatment by using blood tests to track genetic changes in tumors as they progress from their very earliest stages.